Studies on Insulin and liver disease

Elevated insulin, proinsulin and insulin-like growth factor-binding protein-1 in liver disease.
2003 Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society

Impaired insulin-mediated amino acid plasma disappearance in non-alcoholic fatty liver disease: a feature of Insulin resistance.
2003 Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Branched-chain amino acid-enriched supplementation improves Insulin resistance in patients with chronic liver disease.
2008 International journal of molecular medicine

Increased prevalence of Insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.
2006 Proceedings of the National Academy of Sciences of the United States of America

Association of nonalcoholic fatty liver disease with Insulin resistance.
1999 The American journal of medicine

Insulin Resistance Is Independently Associated with Liver Aminotransferases in Diabetic Patients Without Ultrasound Signs of Nonalcoholic Fatty Liver Disease.
2010 Metabolic syndrome and related disorders

Association of nonalcoholic fatty liver disease with Insulin resistance.
1999 The American journal of medicine

Association of nonalcoholic fatty liver disease with Insulin resistance.
1999 The American journal of medicine

Mechanism of hepatic Insulin resistance in non-alcoholic fatty liver disease.
2004 The Journal of biological chemistry

Association of nonalcoholic fatty liver disease with Insulin resistance.
1999 The American journal of medicine

Albuminuria and Insulin resistance in children with biopsy proven non-alcoholic fatty liver disease.
2009 Pediatric nephrology (Berlin, Germany)

Insulin resistance in experimental alcohol-induced liver disease.
2008 Journal of gastroenterology and hepatology

Overexpression of liver-specific cytochrome P4502E1 impairs hepatic Insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease.
2009 European journal of gastroenterology & hepatology

Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease.
1996 Journal of hepatology

Inhibition of protein kinase Cepsilon prevents hepatic Insulin resistance in nonalcoholic fatty liver disease.
2007 The Journal of clinical investigation

Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease.
1996 Journal of hepatology

Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review.
2006 World journal of gastroenterology : WJG

Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease.
2009 Acta diabetologica

Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status.
2009 Advances in therapy

Insulin resistance: a metabolic pathway to chronic liver disease.
2005 Hepatology (Baltimore, Md.)

The association between non-alcoholic fatty liver disease and Insulin resistance in 20 obese children and adolescents.
2007 Acta paediatrica (Oslo, Norway : 1992)

Nonalcoholic fatty liver disease, adiponectin and Insulin resistance in dipper and nondipper essential hypertensive patients.
2008 Journal of hypertension

Branched-chain amino acids improve Insulin resistance in patients with hepatitis C virus-related liver disease: report of two cases.
2007 Liver international : official journal of the International Association for the Study of the Liver

TNFalpha genotype affects TNFalpha release, Insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.
2005 Journal of hepatology

Review: The role of Insulin resistance in nonalcoholic fatty liver disease.
2006 The Journal of clinical endocrinology and metabolism

Obesity, Insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
2003 The Journal of pediatrics

Obesity, Insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease.
2003 The Journal of pediatrics

A case-control study on Insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.
2009 The Indian journal of medical research

Iron depletion by phlebotomy improves Insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
2007 The American journal of gastroenterology

Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle Insulin resistance in overweight adolescents.
2008 The American journal of clinical nutrition

Visceral fat accumulation and Insulin resistance are important factors in nonalcoholic fatty liver disease.
2006 Journal of gastroenterology

Early interplay of intra-hepatic iron and Insulin resistance in children with non-alcoholic fatty liver disease.
2010 Journal of hepatology

Tumor necrosis factor alpha promoter polymorphisms and Insulin resistance in nonalcoholic fatty liver disease.
2002 Gastroenterology

Apoptosis and Insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease.
2011 Diabetologia

Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and Insulin resistance of non alcoholic fatty liver disease.
2009 European review for medical and pharmacological sciences

Low ghrelin concentrations in nonalcoholic fatty liver disease are related to Insulin resistance.
2003 The Journal of clinical endocrinology and metabolism

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.
2004 Gut

Factors associated with Insulin resistance and non-alcoholic fatty liver disease among youths.
2009 Atherosclerosis

Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease.
2005 The Journal of clinical endocrinology and metabolism

Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.
2004 Journal of gastroenterology and hepatology

Hypoadiponectinemia and Insulin resistance are associated with nonalcoholic fatty liver disease.
2005 Journal of Korean medical science

Body fat distribution and Insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men.
2007 Journal of the American College of Nutrition

Circulating adiponectin reflects severity of liver disease but not Insulin sensitivity in liver cirrhosis.
2005 Journal of internal medicine

Effect of spironolactone and vitamin E on serum metabolic parameters and Insulin resistance in patients with nonalcoholic fatty liver disease.
2011 Journal of the renin-angiotensin-aldosterone system : JRAAS

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.
2005 Diabetologia

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic Insulin resistance and hepatic fat content, not to liver disease severity.
2005 The Journal of clinical endocrinology and metabolism

Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
2006 American journal of physiology. Endocrinology and metabolism

Insulin resistance in nonalcoholic fatty liver disease.
2010 Current pharmaceutical design

Non-alcoholic fatty liver disease (NAFLD), Insulin resistance and lipid profile in antiepileptic drug treatment.
2009 Epilepsy research

Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and Insulin action in obese subjects with nonalcoholic fatty liver disease.
2010 The Journal of clinical endocrinology and metabolism

Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or Insulin resistance.
2008 Gut

Comparative evaluation of whole body and hepatic Insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic Fatty liver disease.
2010 Journal of obesity (Online)

Role of -55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and Insulin resistance in patients with obesity.
2010 Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral

Non-alcoholic fatty liver disease and its association with obesity, Insulin resistance and increased serum levels of C-reactive protein in Hispanics.
2009 Liver international : official journal of the International Association for the Study of the Liver

Serum leptin and Insulin in paediatric end-stage liver disease and following successful orthotopic liver transplantation.
1998 Clinical endocrinology

Tumor necrosis factor and its potential role in Insulin resistance and nonalcoholic fatty liver disease.
2004 Clinics in liver disease

Serum leptin and Insulin in paediatric end-stage liver disease and following successful orthotopic liver transplantation.
1998 Clinical endocrinology

Hyperinsulinemia and the development of nonalcoholic Fatty liver disease in nondiabetic adults.
2011 The American journal of medicine

Activation of p53 enhances apoptosis and Insulin resistance in a rat model of alcoholic liver disease.
2011 Journal of hepatology

Serum leptin and Insulin in paediatric end-stage liver disease and following successful orthotopic liver transplantation.
1998 Clinical endocrinology

Insulin tolerance test is comparable to homeostasis model assessment for Insulin resistance in patients with nonalcoholic fatty liver disease.
2007 Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology

Nonalcoholic fatty liver disease as a complication of Insulin resistance.
2007 The Medical clinics of North America

Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
1996 The Journal of clinical endocrinology and metabolism

Potential role of interleukin-18 in liver disease associated with Insulin resistance.
2005 Obesity research

Epigenetic regulation of Insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor ? coactivator 1a promoter.
2010 Hepatology (Baltimore, Md.)

Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of Insulin resistance.
2009 Journal of diabetes

Leptin, Insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
2004 Journal of hepatology

The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation.
1998 Pediatric transplantation

Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
1996 The Journal of clinical endocrinology and metabolism

Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ Insulin sensitivity in obese subjects with non-alcoholic fatty liver disease.
2010 International journal of obesity (2005)

Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to Insulin resistance.
2006 The Journal of clinical endocrinology and metabolism

Influence of Insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease.
2008 Digestive diseases and sciences

Increased acylation stimulating protein concentrations in nonalcoholic fatty liver disease are associated with Insulin resistance.
2005 The American journal of gastroenterology

Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
1996 The Journal of clinical endocrinology and metabolism

Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease.
2004 Clinics in liver disease

Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
1996 The Journal of clinical endocrinology and metabolism

Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients.
2004 International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity

Association of nonalcoholic fatty liver disease with Insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?
2003 Journal of clinical gastroenterology

Association of nonalcoholic fatty liver disease with Insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?
2003 Journal of clinical gastroenterology

Mitochondrial dysfunction precedes Insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model.
2010 Journal of hepatology

Effect of two different hypocaloric diets in transaminases and Insulin resistance in nonalcoholic fatty liver disease and obese patients.
2010 Nutricion hospitalaria : organo oficial de la Sociedad Espanola de Nutricion Parenteral y Enteral

[Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.].
2009 Zhonghua nei ke za zhi [Chinese journal of internal medicine]

The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and Insulin resistance.
2010 American journal of physiology. Gastrointestinal and liver physiology

Increased soluble leptin receptor levels in morbidly obese patients with Insulin resistance and nonalcoholic fatty liver disease.
2010 Obesity (Silver Spring, Md.)

Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with Insulin resistance.
2009 European journal of gastroenterology & hepatology

Induction of non-alcoholic fatty liver disease and Insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?
2009 Nutrition (Burbank, Los Angeles County, Calif.)

SREBP-1c, regulated by the Insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
2008 International journal of molecular medicine

Beneficial effects of exercise training (treadmill) on Insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice.
2010 Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.]

Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, Insulin resistance, and waist circumference.
2009 Environmental health and preventive medicine

Genetic variants regulating Insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.
2010 Gut

The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women.
2008 AIDS (London, England)

Bile acids and Insulin resistance: implications for treating nonalcoholic fatty liver disease.
2009 Journal of digestive diseases

Nonalcoholic fatty liver disease: the pathogenetic roles of Insulin resistance and adipocytokines.
2009 Current molecular medicine

Is there any association between high-density lipoprotein, Insulin resistance and non-alcoholic fatty liver disease in obese children?
2009 International journal of food sciences and nutrition

Nutritional modulation of nonalcoholic fatty liver disease and Insulin resistance: human data.
2010 Current opinion in clinical nutrition and metabolic care

A novel agonist of PPAR-? based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing Insulin resistance.
2011 European journal of pharmacology

Insulin-like growth factors I and II are reduced in plasma from growth retarded children with chronic liver disease.
1994 Growth regulation

Relationships between estimates of adiposity, Insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
2007 Diabetes care

Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
2007 Gastroenterology

Non-alcoholic fatty liver disease and Insulin resistance.
2005 European journal of gastroenterology & hepatology

Effect of vitamin E on aminotransferase levels and Insulin resistance in children with non-alcoholic fatty liver disease.
2006 Alimentary pharmacology & therapeutics

Insulin resistance, inflammation, and non-alcoholic fatty liver disease.
2008 Trends in endocrinology and metabolism: TEM

Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis.
2006 Journal of gastroenterology

Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and Insulin resistance.
2006 Obesity surgery

Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
2006 Trends in molecular medicine

Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study.
1998 Pediatric research

Nutrient intake in Italian obese patients: Relationships with Insulin resistance and markers of non-alcoholic fatty liver disease.
2010 Nutrition (Burbank, Los Angeles County, Calif.)

Role of nonalcoholic fatty liver disease in the development of Insulin resistance and diabetes.
2008 Expert review of gastroenterology & hepatology

Non-alcoholic fatty liver disease. From Insulin resistance to mitochondrial dysfunction.
2006 Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva

Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study.
1998 Pediatric research

[Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
2006 Zhonghua yi xue za zhi

Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with Insulin resistance.
2008 Diabetes research and clinical practice

Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study.
1998 Pediatric research

Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease.
1997 Hepatology (Baltimore, Md.)

Treatment with Insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial.
2011 Metabolism: clinical and experimental

Nonalcoholic fatty liver disease: relationship to Insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine.
2002 Alternative medicine review : a journal of clinical therapeutic

Liver steatosis, but not fibrosis, is associated with Insulin resistance in nonalcoholic fatty liver disease.
2007 Journal of gastroenterology

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for Insulin resistance and diabetes.
2008 Hepatology (Baltimore, Md.)

Impact of nonalcoholic fatty liver disease on Insulin resistance in relation to HbA1c levels in nondiabetic subjects.
2010 The American journal of gastroenterology

Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease.
2010 European journal of gastroenterology & hepatology

Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease.
1997 Hepatology (Baltimore, Md.)

Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from Insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis.
2009 Canadian journal of gastroenterology = Journal canadien de gastroenterologie

Relation of osteocalcin with Insulin resistance and histopathological changes of non alcoholic fatty liver disease.
2011 Annals of hepatology : official journal of the Mexican Association of Hepatology

Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic Insulin sensitivity and hepatic fat accumulation?
2010 Drug discovery today

Cissus quadrangularis stem alleviates Insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet.
2010 Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study.
1998 Pediatric research

Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density.
2001 Liver

Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease.
2007 Hepatology international

[Non-alcoholic fatty liver disease in dyslipidemia and Insulin resistance: similarities and differences; differential approach to therapy].
2009 Eksperimental'nai?a i klinicheskai?a gastroenterologii?a = Experimental & clinical gastroenterology

Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.
2011 Liver international : official journal of the International Association for the Study of the Liver

Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals.
2010 Arquivos de gastroenterologia

Serum dipeptidyl peptidase-4 activity in Insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.
2010 PloS one

Post-load Insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
2007 Gut

Drugs improving Insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
2007 Cochrane database of systematic reviews (Online)

Nonalcoholic fatty liver disease is associated with Insulin resistance in a young Hispanic population.
2011 Preventive medicine

Non-alcoholic fatty liver disease and Insulin resistance: importance of risk factors and histological spectrum.
2005 European journal of gastroenterology & hepatology

Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease.
2006 World journal of gastroenterology : WJG

Familial aggregation of Insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease.
2006 Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

G308A polymorphism of TNF-alpha gene is associated with Insulin resistance and histological changes in non alcoholic fatty liver disease patients.
2010 Annals of hepatology : official journal of the Mexican Association of Hepatology

Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation.
2002 Hormone research

Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
2008 Obesity surgery

Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
2010 Muscle & nerve

Anthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease.
2008 Paediatrics & child health

[Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].
2009 Zhonghua er ke za zhi. Chinese journal of pediatrics

Diabetes in chronic liver disease: from old concepts to new evidence.
2006 Diabetes/metabolism research and reviews

Predictors of non-alcoholic fatty liver disease in obese children.
2007 European journal of clinical nutrition

Role of mitochondria in non-alcoholic fatty liver disease.
2007 Journal of gastroenterology and hepatology

[Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes.]
2011 Zhonghua er ke za zhi. Chinese journal of pediatrics

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
2001 Diabetes

Metformin reverses fatty liver disease in obese, leptin-deficient mice.
2000 Nature medicine

Aerobic exercise: a potential therapeutic intervention for patients with liver disease.
2004 Medical hypotheses

Metformin reverses fatty liver disease in obese, leptin-deficient mice.
2000 Nature medicine

The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.
2006 Metabolism: clinical and experimental

Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease.
2010 Hepatology (Baltimore, Md.)

Metformin reverses fatty liver disease in obese, leptin-deficient mice.
2000 Nature medicine

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
2001 Diabetes

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
2001 Diabetes

Metformin reverses fatty liver disease in obese, leptin-deficient mice.
2000 Nature medicine

Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.
2009 Hepatology (Baltimore, Md.)

Protective role of coffee in non-alcoholic fatty liver disease (NAFLD).
2010 Digestive diseases and sciences

Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.
2010 Metabolism: clinical and experimental

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
2001 Diabetes

Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents.
2010 Journal of obesity (Online)

Olive oil consumption and non-alcoholic fatty liver disease.
2009 World journal of gastroenterology : WJG

Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
2009 Diabetes/metabolism research and reviews

Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: a descriptive analysis.
2010 South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence?
2010 Obesity surgery

Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease.
2009 Hepatology research : the official journal of the Japan Society of Hepatology

Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease.
1999 Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.
2005 Nature clinical practice. Gastroenterology & hepatology

Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease.
1999 Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease.
1999 Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Interferon-alpha improves glucose tolerance in diabetic and non-diabetic patients with HCV-induced liver disease.
1999 Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association

Diabetes co-existing with chronic liver disease: clinical features and response to therapy.
2007 Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria

Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
2006 Journal of Zhejiang University. Science. B

Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism.
2010 International journal of obesity (2005)

[Prevalence of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome: a case-control study].
2008 Zhonghua fu chan ke za zhi

A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
2004 Journal of hepatology